IN THE NEWS
Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market Leaders
ESTERO, FL February 23, 2023 (GLOBE NEWSWIRE) – Mushrooms, Inc. (OTC: MSRM) (the “Company”) has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology.
Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Positioning for Global Acquisitions and Shareholder Update
ESTERO, Fla., Oct. 28, 2022 (GLOBE NEWSWIRE) -- Marijuana Strategic Ventures, Inc. (the “Company”)(OTC: MSVI) now Mushrooms Inc., Announces Positioning for Global Acquisitions and Shareholder Update. Direction: The Company is pleased to announce that the resources that were allocated for the development and sales of Telogenix, a company developing nutraceutical mushroom products, has been re-allocated to the development of the Company’s own proprietary provisional patent technology and mushroom related business acquisitions.
Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc. Shares Industry Highlights of the Industrial Mushroom Market for Investor Awareness
ESTERO, Fla., July 28, 2022 (GLOBE NEWSWIRE) -- Marijuana Strategic Ventures, Inc. (the “Company”)(OTC: MSVI) now Mushrooms Inc. shares industry highlights of the industrial mushroom market for investor awareness. Mushrooms Inc – Marijuana Strategic Ventures has changed its name to Mushrooms Inc. We are awaiting official name and ticker changes while we make headway in the industrial mushroom market, functional mushroom market and mushroom related innovation. The purpose of this release is to bring awareness to the success of the newly developing industrial mushroom market.
Marijuana Strategic Ventures, Inc. (OTC: MSVI) Announces Name Change to Mushrooms, Inc., New Management and Business Model
ESTERO, Fla, July 05, 2022 (GLOBE NEWSWIRE) -- Marijuana Strategic Ventures, Inc. (the “Company”) (OTC:MSVI) announces today that effective June 27, 2022, the Company has officially changed its name to Mushrooms, Inc., through the filing of amended and restated articles of incorporation with the Nevada Secretary of State. In addition to changing the Company’s corporate name to Mushrooms, Inc., the Company announces the appointment of a new Chief Executive Officer, Kimberly Carlson, focused on implementing a new business model based on functional mushrooms. With the appointment of Kimberly Carlson as CEO, the Company’s former CEO, James Hancock, has been appointed the Chief Operating Officer of the Company. James Hancock resigned from the Company’s board of directors, leaving Donald Steinberg as the Company’s sole director.
Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM”
Estero, FL, November 29, 2022 – Mushrooms Inc. (OTC: MSRM) (the “Company”), formerly Marijuana Strategic Ventures, Inc., is pleased to announce that, effective November 29, 2022, the Company’s ticker symbol on the OTC Markets has changed from “MSVI” to its new symbol, “MSRM” and has been announced to FINRA’s daily list. The Company’s name change, which became effective with Nevada Secretary of State on June 28, 2022, has now also been reflected on OTC Markets.
It is important to note that Mushrooms, Inc. is the first company trading on the US stock market focused on the industrial side of Mushrooms.
Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread
ESTERO, Fla., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Marijuana Strategic Ventures, Inc. (the “Company”)(OTC: MSVI) now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread. Mushrooms Inc. Update – The Company is pleased to announce that on August 22, 2022, Mushrooms, Inc. executed an exclusive license agreement for all rights to a newly filed provisional patent for a novel mycelium thread manufacturing method with the United States Patent Office (USPTO).
Marijuana Strategic Ventures, Inc. (OTC: MSVI) Announces Updates for Mushrooms, Inc., Health Product Production, Provisional Patent and Business Plan Development
ESTERO, Fla., July 15, 2022 (GLOBE NEWSWIRE) -- Marijuana Strategic Ventures, Inc. (the “Company”) (OTC: MSVI) announces updates to the progress of its three areas of focus: Health, Innovation and Research & Development. In Health, the Company has secured sourcing for the 4 Telogenix products currently listed on the website, www.mushroomsinc.com, as well as 2 additional products: one specific to athletes and another for removal of plaque from the arteries. All the ingredients are certified organic, non-GMO, gluten free and fair trade. The capsules for each product will be made and packaged in California. We are working towards the goal of product availability at the end of September. We are simultaneously working on product placement in organic focused, health-oriented stores as well as online.
Mushrooms Inc. - MEDIA BUZZ
The Media is paying Attention to us!
Industry News
Alexander McQueen presents mycelium-inspired collection in first New York show in 20 years
British brand unveiled its latest creations in a Brooklyn warehouse this week
Mar 17, 2022
The Alexander McQueen design team were already marvelling at the connective properties of mycelium, the expansive, thread-like fungal networks that spawn mushrooms. And then they came across a giant oyster mushroom sprouting from the concrete floor of an abandoned space on the fifth floor of their London office block. It felt like a sign.
So mycelium became the reference point for the brand’s autumn/winter 2022 collection, which was unveiled in New York on Tuesday. This was Alexander McQueen’s first show in the city in more than two decades and, in keeping with the overarching theme, represented an opportunity to reconnect, said creative director Sarah Burton in her show notes.
Dell to use mushroom-based cushioning
Computer leader Dell has been testing cushioning made from a new "rapid renewable" material—mushrooms—and is now ready to use the packaging commercially for a variety of computer and electronic products.
As Oliver Campbell, head of the Dell packaging team, explained to Gearlog.com, "The process works like this: Waste product like cotton hulls are placed in a mold which is then inoculated with mushroom spawn. Our cushions take five to 10 days to grow as the spawn, which become the root structure—or by the scientific name, mycelium—of the mushroom. All the energy needed to form the cushion is supplied by the carbohydrates and sugars in the ag waste. There's no need for energy based on carbon or nuclear fuels."
The EcoCradle Mushroom packaging from Ecovative is one of several initiatives that Dell is using to help it reach its goal of eliminating 20 million pounds of packaging waste by 2012.
According to the supplier, Ecovative mushroom engineers worked with the Dell packaging team over the last eight months to develop a new formulation of EcoCradle, based around local cotton waste found near Dell's Austin, Texas, manufacturing facility, that could not only support the 100-lb servers, but could also provide the required shock absorption.
Engineered mycelium composite construction materials from fungal biorefineries: A critical review
Author links open overlay panel
Significant pressure has been applied to the construction industry over the past decade, as the supply of traditional construction materials, such as cement, bricks, timber, cladding and partitioning materials, has struggled to keep up with an ever-increasing global population.
Mycelium composites are an emerging class of cheap and environmentally sustainable materials experiencing increasing research interest and commercialisation in the EU and USA for construction applications. These materials utilise natural fungal growth as a low energy bio-fabrication method to upcycle abundant agricultural by-products and wastes into more sustainable alternatives to energy intensive synthetic construction materials. Mycelium composites have customisable material properties based on their composition and manufacturing process and can replace foams, timber and plastics for applications, such as insulation, door cores, panelling, flooring, cabinetry and other furnishings. Due to their low thermal conductivity, high acoustic absorption and fire safety properties outperforming traditional construction materials, such as synthetic foams and engineered woods, they show particular promise as thermal and acoustic insulation foams. However, limitations stemming from their typically foam-like mechanical properties, high water absorption and many gaps in material property documentation necessitate the use of mycelium composites as non- or semi-structural supplements to traditional construction materials for specific, suitable applications, including insulation, panelling and furnishings. Nonetheless, useful material properties in addition to the low costs, simplicity of manufacture and environmental sustainability of these materials suggest that they will play a significant role in the future of green construction.
